• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于RNA递送的仿生脂质纳米载体

Bioinspired Lipid Nanocarriers for RNA Delivery.

作者信息

Golubovic Alex, Tsai Shannon, Li Bowen

机构信息

Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario M5S 3M2, Canada.

Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada.

出版信息

ACS Bio Med Chem Au. 2023 Jan 16;3(2):114-136. doi: 10.1021/acsbiomedchemau.2c00073. eCollection 2023 Apr 19.

DOI:10.1021/acsbiomedchemau.2c00073
PMID:37101812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10125326/
Abstract

RNA therapy is a disruptive technology comprising a rapidly expanding category of drugs. Further translation of RNA therapies to the clinic will improve the treatment of many diseases and help enable personalized medicine. However, in vivo delivery of RNA remains challenging due to the lack of appropriate delivery tools. Current state-of-the-art carriers such as ionizable lipid nanoparticles still face significant challenges, including frequent localization to clearance-associated organs and limited (1-2%) endosomal escape. Thus, delivery vehicles must be improved to further unlock the full potential of RNA therapeutics. An emerging strategy is to modify existing or new lipid nanocarriers by incorporating bioinspired design principles. This method generally aims to improve tissue targeting, cellular uptake, and endosomal escape, addressing some of the critical issues facing the field. In this review, we introduce the different strategies for creating bioinspired lipid-based RNA carriers and discuss the potential implications of each strategy based on reported findings. These strategies include incorporating naturally derived lipids into existing nanocarriers and mimicking bioderived molecules, viruses, and exosomes. We evaluate each strategy based on the critical factors required for delivery vehicles to succeed. Finally, we point to areas of research that should be furthered to enable the more successful rational design of lipid nanocarriers for RNA delivery.

摘要

RNA疗法是一种颠覆性技术,包含一类迅速扩展的药物。将RNA疗法进一步转化应用于临床将改善多种疾病的治疗,并有助于实现个性化医疗。然而,由于缺乏合适的递送工具,RNA的体内递送仍然具有挑战性。当前最先进的载体,如可电离脂质纳米颗粒,仍然面临重大挑战,包括频繁定位于与清除相关的器官以及有限的(1%-2%)内体逃逸率。因此,必须改进递送载体,以进一步释放RNA疗法的全部潜力。一种新兴策略是通过纳入受生物启发的设计原则来修饰现有的或新型的脂质纳米载体。这种方法通常旨在改善组织靶向性、细胞摄取和内体逃逸,解决该领域面临的一些关键问题。在这篇综述中,我们介绍了创建受生物启发的基于脂质的RNA载体的不同策略,并根据已报道的研究结果讨论了每种策略的潜在影响。这些策略包括将天然衍生的脂质纳入现有的纳米载体以及模仿生物衍生分子、病毒和外泌体。我们根据递送载体成功所需的关键因素评估每种策略。最后,我们指出了为实现更成功的用于RNA递送的脂质纳米载体的合理设计而应进一步开展研究的领域。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/4100e26c046e/bg2c00073_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/ab127fc3636e/bg2c00073_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/5a48fbec9d85/bg2c00073_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/d5bb5ca63b97/bg2c00073_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/4100e26c046e/bg2c00073_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/ab127fc3636e/bg2c00073_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/5a48fbec9d85/bg2c00073_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/d5bb5ca63b97/bg2c00073_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f72/10125326/4100e26c046e/bg2c00073_0004.jpg

相似文献

1
Bioinspired Lipid Nanocarriers for RNA Delivery.用于RNA递送的仿生脂质纳米载体
ACS Bio Med Chem Au. 2023 Jan 16;3(2):114-136. doi: 10.1021/acsbiomedchemau.2c00073. eCollection 2023 Apr 19.
2
Lipid-Based Nanocarriers for RNA Delivery.用于RNA递送的脂质基纳米载体
Curr Pharm Des. 2015;21(22):3140-7. doi: 10.2174/1381612821666150531164540.
3
The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids.设计用于递送核糖核酸的有效可离子化材料时的工程挑战和机遇。
Expert Opin Drug Deliv. 2022 Dec;19(12):1650-1663. doi: 10.1080/17425247.2022.2144827. Epub 2022 Nov 21.
4
Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.用于癌症治疗中 siRNA 递送的基于脂质的纳米颗粒:范例与挑战。
Acc Chem Res. 2012 Jul 17;45(7):1163-71. doi: 10.1021/ar300048p. Epub 2012 May 8.
5
Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics.脂质纳米颗粒技术在 siRNA 治疗药物临床转化中的应用
Acc Chem Res. 2019 Sep 17;52(9):2435-2444. doi: 10.1021/acs.accounts.9b00368. Epub 2019 Aug 9.
6
Lipid nanocarriers for microRNA delivery.用于 miRNA 递送的脂质纳米载体。
Chem Phys Lipids. 2020 Jan;226:104837. doi: 10.1016/j.chemphyslip.2019.104837. Epub 2019 Nov 2.
7
Iterative Design of Ionizable Lipids for Intramuscular mRNA Delivery.用于肌内 mRNA 递送的可离子化脂质的迭代设计。
J Am Chem Soc. 2023 Feb 1;145(4):2294-2304. doi: 10.1021/jacs.2c10670. Epub 2023 Jan 18.
8
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
9
Lipid-Based Nanocarriers: Bridging Diagnosis and Cancer Therapy.脂质基纳米载体:连接诊断与癌症治疗
Pharmaceutics. 2024 Sep 1;16(9):1158. doi: 10.3390/pharmaceutics16091158.
10
Cell-free synthesis of connexin 43-integrated exosome-mimetic nanoparticles for siRNA delivery.无细胞合成连接蛋白 43 整合的外泌体模拟纳米颗粒用于 siRNA 递释。
Acta Biomater. 2019 Sep 15;96:517-536. doi: 10.1016/j.actbio.2019.07.006. Epub 2019 Jul 5.

引用本文的文献

1
Insights on Natural Membrane Characterization for the Rational Design of Biomimetic Drug Delivery Systems.用于仿生药物递送系统合理设计的天然膜表征见解。
Pharmaceutics. 2025 Jun 27;17(7):841. doi: 10.3390/pharmaceutics17070841.
2
Delivery strategies for RNA-targeting therapeutic nucleic acids and RNA-based vaccines against respiratory RNA viruses: IAV, SARS-CoV-2, RSV.针对呼吸道RNA病毒(甲型流感病毒、严重急性呼吸综合征冠状病毒2、呼吸道合胞病毒)的RNA靶向治疗性核酸和基于RNA的疫苗的递送策略
Mol Ther Nucleic Acids. 2025 May 20;36(3):102572. doi: 10.1016/j.omtn.2025.102572. eCollection 2025 Sep 9.
3
Berberine hydrochloride-loaded liposomes-in-hydrogel microneedles achieve the efficient treatment for psoriasis.

本文引用的文献

1
The landscape of mRNA nanomedicine.信使核糖核酸纳米药物的前景。
Nat Med. 2022 Nov;28(11):2273-2287. doi: 10.1038/s41591-022-02061-1. Epub 2022 Nov 10.
2
Unlocking the promise of mRNA therapeutics.解锁 mRNA 疗法的潜力。
Nat Biotechnol. 2022 Nov;40(11):1586-1600. doi: 10.1038/s41587-022-01491-z. Epub 2022 Nov 3.
3
A lung targeted miR-29 mimic as a therapy for pulmonary fibrosis.一种肺靶向 miR-29 模拟物作为治疗肺纤维化的方法。
载有盐酸小檗碱的脂质体水凝胶微针实现了对银屑病的有效治疗。
Mater Today Bio. 2025 Apr 25;32:101795. doi: 10.1016/j.mtbio.2025.101795. eCollection 2025 Jun.
4
Rational design and modular synthesis of biodegradable ionizable lipids via the Passerini reaction for mRNA delivery.通过Passerini反应进行可生物降解的可电离脂质的合理设计与模块化合成用于mRNA递送。
Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2409572122. doi: 10.1073/pnas.2409572122. Epub 2025 Jan 30.
5
Extracellular vesicle mimetics as delivery vehicles for oligonucleotide-based therapeutics and plasmid DNA.细胞外囊泡模拟物作为基于寡核苷酸的治疗药物和质粒DNA的递送载体。
Front Bioeng Biotechnol. 2024 Oct 17;12:1437817. doi: 10.3389/fbioe.2024.1437817. eCollection 2024.
6
The multifaceted roles of circular RNAs in cancer hallmarks: From mechanisms to clinical implications.环状RNA在癌症特征中的多方面作用:从机制到临床意义
Mol Ther Nucleic Acids. 2024 Jul 20;35(3):102286. doi: 10.1016/j.omtn.2024.102286. eCollection 2024 Sep 10.
7
Synergistic vesicle-vector systems for targeted delivery.协同囊泡载体系统用于靶向递药。
J Nanobiotechnology. 2024 Jan 3;22(1):6. doi: 10.1186/s12951-023-02275-6.
EBioMedicine. 2022 Nov;85:104304. doi: 10.1016/j.ebiom.2022.104304. Epub 2022 Oct 17.
4
Phosphatidylserine Lipid Nanoparticles Promote Systemic RNA Delivery to Secondary Lymphoid Organs.磷脂酰丝氨酸脂质纳米颗粒促进系统性 RNA 递送至次级淋巴器官。
Nano Lett. 2022 Oct 26;22(20):8304-8311. doi: 10.1021/acs.nanolett.2c03234. Epub 2022 Oct 4.
5
Engineering Lipid Nanoparticles for Enhanced Intracellular Delivery of mRNA through Inhalation.通过吸入方式将 mRNA 递送至细胞内的工程化脂质纳米颗粒
ACS Nano. 2022 Sep 27;16(9):14792-14806. doi: 10.1021/acsnano.2c05647. Epub 2022 Aug 29.
6
Oral delivery of IL-22 mRNA-loaded lipid nanoparticles targeting the injured intestinal mucosa: A novel therapeutic solution to treat ulcerative colitis.口服负载白细胞介素-22信使核糖核酸的脂质纳米颗粒靶向损伤的肠黏膜:一种治疗溃疡性结肠炎的新型治疗方案。
Biomaterials. 2022 Sep;288:121707. doi: 10.1016/j.biomaterials.2022.121707. Epub 2022 Aug 3.
7
Effectiveness of Comirnaty Vaccine and Correlates of Immunogenicity and Adverse Reactions: A Single-Center Prospective Case Series Study.辉瑞新冠疫苗的有效性及免疫原性和不良反应的相关因素:一项单中心前瞻性病例系列研究。
Vaccines (Basel). 2022 Jul 22;10(8):1170. doi: 10.3390/vaccines10081170.
8
Sendai F/HN pseudotyped lentiviral vector transduces human ciliated and non-ciliated airway cells using α 2,3 sialylated receptors.仙台F/HN假型慢病毒载体利用α2,3唾液酸化受体转导人纤毛和非纤毛气道细胞。
Mol Ther Methods Clin Dev. 2022 Jul 6;26:239-252. doi: 10.1016/j.omtm.2022.07.002. eCollection 2022 Sep 8.
9
Respiratory mucosal immunity against SARS-CoV-2 after mRNA vaccination.mRNA 疫苗接种后针对 SARS-CoV-2 的呼吸道黏膜免疫。
Sci Immunol. 2022 Oct 28;7(76):eadd4853. doi: 10.1126/sciimmunol.add4853. Epub 2022 Oct 21.
10
Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines.体内脂纳米粒的肝外靶向与细胞内靶向用于未来的纳米药物。
Adv Drug Deliv Rev. 2022 Sep;188:114417. doi: 10.1016/j.addr.2022.114417. Epub 2022 Jul 3.